MARSHALL WACE, LLP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 52 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$741,419
-75.1%
72,475
-75.5%
0.00%
-71.4%
Q4 2022$2,973,655
+1.9%
295,8860.0%0.01%
+16.7%
Q3 2022$2,918,000
+9.0%
295,886
+7.6%
0.01%0.0%
Q2 2022$2,677,000
-0.2%
274,9750.0%0.01%
+20.0%
Q1 2022$2,683,000
+0.9%
274,9750.0%0.01%0.0%
Q4 2021$2,660,000
-1.6%
274,9750.0%0.01%
-54.5%
Q3 2021$2,703,000274,9750.01%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q4 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,199,000$11,672,0000.82%
MMCAP International Inc. SPC 800,000$7,788,0000.62%
Arena Capital Advisors, LLC- CA 250,917$2,443,0000.62%
Atalaya Capital Management LP 500,000$4,870,0000.58%
DG Capital Management, LLC 127,665$1,243,0000.45%
Kepos Capital LP 500,000$4,868,0000.44%
KIM, LLC 800,000$7,792,0000.37%
ANGELO GORDON & CO., L.P. 300,000$2,921,0000.32%
FIR TREE CAPITAL MANAGEMENT LP 950,803$9,261,0000.29%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,868,0000.28%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders